Pharma Focus Asia

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

AusperBio Therapeutics Introduces Novel AHB-137 for Chronic Hepatitis B Treatment

AusperBio Therapeutics has introduced AHB-137, a groundbreaking treatment for chronic hepatitis B (CHB). With approximately 296 million people globally affected by chronic HBV and limited treatment options for a cure, the disease...

Sanofi Unveils Ground breaking Dupixent Therapy for Chronic Obstructive Pulmonary Disease

Sanofi has introduced Dupixent, a groundbreaking addition to maintenance therapy for adults suffering from uncontrolled chronic obstructive pulmonary disease characterised by elevated blood...

Eli Lilly Introduced First-of-its-kind Kisunla™ for Alzheimer's Disease

Eli Lilly has launched Kisunla™, a groundbreaking therapy for adults with early symptomatic Alzheimer's disease, encompassing those with mild cognitive impairment...

Ligand Pharmaceuticals Develops Novel Ohtuvayre™ for the Treatment of Chronic Obstructive Pulmonary Disease

Ligand Pharmaceuticals has developed Ohtuvayre™, the first inhaled treatment with a novel mechanism for chronic obstructive pulmonary disease in over 20 years....

Aurion Biotech Developed Novel Drug Candidate AURN001

Aurion Biotech has introduced AURN001, a novel treatment developed for addressing corneal oedema resulting from corneal endothelial disease....

Dizal Launches First-in-class Golidocitinib Inhibitor for Relapsed or Refractory Peripheral T-Cell Lymphoma

Dizal has introduced golidocitinib as a pioneering treatment specifically for adult patients suffering from relapsed or refractory peripheral T-cell lymphoma, a form of aggressive non-Hodgkin lymphoma...

Cranbury Pharmaceuticals Introduces First-of-its-kind Emflaza® for Duchenne Muscular Dystrophy (DMD)

Cranbury Pharmaceuticals has introduced a groundbreaking product, Emflaza® oral suspension, designed specifically for treating Duchenne muscular dystrophy...

Loma Linda University Health Developed First-of-its-kind Gene Therapy for Hemophilia

Loma Linda University Health has achieved a groundbreaking milestone with the development of a pioneering gene therapy for hemophilia B, complemented by dirloctocogene samoparvovec, an advanced...

Spinogenix Discovered SPG302, a Novel Therapy for the Treatment of Amyotrophic lateral sclerosis (ALS)

Spinogenix has discovered a novel treatment, SPG302, for Amyotrophic Lateral Sclerosis. SPG302 is a once-daily pill developed as a regenerative therapy for ALS...

UC San Diego Health Introduced Novel Therapy for Melanoma

UC San Diego Health has unveiled a pioneering immunotherapy treatment for metastatic melanoma, heralding a breakthrough in cancer care. This novel approach utilises personalised cellular therapy...

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference